Why Is Taysha Gene Therapies Stock Trading Higher On Thursday?

benzinga.com/general/biotech/25/05/45677003/why-is-taysha-gene-therapies-stock-trading-higher-on-thursday

Taysha Gene Therapies Inc. (NASDAQ:TSHA) on Wednesday announced details of its planned pivotal Part B trial design for TSHA-102 following written alignment from the U.S. Food and Drug Administration (FDA).
Single-arm, open-label trial with patients serving as their control (intend…

This story appeared on benzinga.com, 2025-05-29 17:06:07.
The Entire Business World on a Single Page. Free to Use →